Dementia Prevention in Kathmandu: What the Evidence Actually Shows

Dementia prevention is one of the most discussed topics in neurology, and also one of the most misunderstood. The honest position is this: no intervention guarantees prevention of dementia. However, a substantial body of evidence identifies modifiable risk factors that, when addressed, reduce the risk of developing dementia. The Lancet Commission on Dementia Prevention, Intervention, and Care (2020 and 2024 updates) provides the most comprehensive evidence synthesis, identifying 14 modifiable risk factors that collectively account for a significant proportion of dementia cases worldwide.

Modifiable risk factors with evidence: Hypertension is the single most impactful vascular risk factor for dementia. Chronic high blood pressure damages cerebral blood vessels over years, contributing to both vascular dementia and Alzheimer's disease pathology. Midlife hypertension (ages 40——65) has the strongest association, but blood pressure management at any age provides benefit. The target is sustained control, not occasional measurement.

Dr. Jitendra Prasad Yadav — consultant neurologist & headache specialist at Kathmandu Neurology Clinic & Cognitive Center provides evidence-based evaluation for dementia.

Diabetes and insulin resistance: Type 2 diabetes increases dementia risk through vascular damage, neuroinflammation, and impaired insulin signalling in the brain. Glycaemic control reduces microvascular complications, and emerging evidence suggests it may also slow cognitive decline, though the relationship is complex.

Smoking: Smoking damages blood vessel walls, increases clot formation, and accelerates atherosclerosis —— all of which affect cerebral perfusion. Cessation at any age reduces risk, and the benefits begin within weeks of stopping.

Hearing loss: The Lancet Commission identified hearing loss as the largest potentially modifiable risk factor for dementia, accounting for approximately 8% of attributable risk. The mechanism is not fully understood but may involve cognitive load (the brain working harder to process degraded auditory input), social isolation, and accelerated brain atrophy. Hearing assessment and amplification when indicated are simple interventions with potential cognitive benefit.

Depression: Depression is both a risk factor for and a prodrome of dementia. Chronic depression is associated with hippocampal atrophy, hypothalamic-pituitary-adrenal axis dysregulation, and reduced neuroplasticity. Treating depression —— with therapy, medication, or both —— may reduce dementia risk, though the evidence is stronger for prevention of recurrence than for primary prevention.

Social isolation: Loneliness and social disconnection accelerate cognitive decline. Social engagement challenges the brain through language processing, memory, attention, and emotional regulation simultaneously —— mechanisms that solitary activities do not replicate. Maintaining family connections, community participation, and meaningful conversation provides cognitive stimulation that no app or supplement replicates.

Physical inactivity: The brain receives 15——20% of cardiac output despite comprising 2% of body mass. Physical activity improves cerebral blood flow, reduces inflammation, and stimulates neurotrophic factors that support neuronal health. Both aerobic exercise (walking, cycling, swimming) and resistance training show benefits. The evidence does not favour one specific exercise type —— consistency matters more than intensity.

Low education and cognitive inactivity: Lower educational attainment is associated with higher dementia risk, though the mechanism is likely cognitive reserve rather than education itself. Maintaining cognitive engagement throughout life —— reading, learning new skills, musical activity, complex occupational demands —— builds resilience against age-related decline.

What the evidence shows: The Lancet Commission estimates that addressing these modifiable risk factors could prevent or delay up to 40% of dementia cases worldwide. This is not a cure, but it is a meaningful reduction. The evidence is strongest for vascular risk management (blood pressure, diabetes, smoking cessation), hearing loss treatment, physical activity, and social engagement.

What does NOT work: Supplements (vitamin E, omega-3, ginkgo biloba, B vitamins in normal populations) have not been shown to prevent dementia in large randomised trials. "Brain training" apps show modest improvements on trained tasks but limited transfer to real-world function. Time and money are better spent on evidence-based interventions —— sleep, exercise, social engagement, and vascular risk management.

Dr. Jitendra's evidence-based approach: At Kathmandu Neurology Clinic & Cognitive Center (Durbar Marg, Opposite of Yak & Yeti Hotel), Dr. Jitendra Prasad Yadav (NMC 8029) discusses dementia prevention during cognitive assessments and memory evaluations. The approach focuses on vascular risk factor optimization, sleep and mood screening, physical activity counselling, social engagement encouragement, and hearing assessment referral when indicated. He is transparent about the limits of evidence —— no intervention guarantees prevention —— and avoids recommending unproven supplements or commercial brain-training products. For patients with mild cognitive impairment or early dementia, the focus shifts to progression monitoring, caregiver support, and safety planning rather than false promises of reversal.

Bring a current medication list, blood pressure records, and any cognitive screening results to your consultation. Early MoCA/MMSE screening guides whether lifestyle modification, vascular workup, or specialist follow-up is the appropriate next step.

This article is educational and does not replace individual medical advice.